Atogepant for the Preventive Treatment of Migraine in Japanese Participants: A Phase 3, Open-Label, 52-Week Extension Study. - Matsumori, Yasuhiko; Nagy, Krisztian; Takahashi, Akihiro; Tanaka, Shigeya; Takeshima, Takao; Forero, Giovanna; Bao, Jia; Guo, Hua; Ahmadyar, Gina; de Abreu Ferreira, Rosa; Yamamoto, Toshimasa (Neurology & Therapy, 2026)